In the purification and separation of bioactive peptides from the crude extract, we found serine amino acid residue at the end and in between the serine moiety with the peptide sequence of Gly-Gly-Ser-Lys and Glu-Leu-Ser. How can we make use of the presence of these two peptide sequences as a potential remedial solution for controlling the incidence of diabetes or what is the possible explanation for the serine amino acid peptide sequence in management of the aggravation of diabetes?? Thanks for your contribution in advance.

More Tilahun Abera's questions See All
Similar questions and discussions